300169.Sz
The company operates in the specialty chemicals industry, producing and selling chemical products for industrial applications, primarily generating revenue through the sale of these products to manufacturing and processing sectors.
Business. The company operates in the specialty chemicals industry, producing and selling chemical products for industrial applications, primarily generating revenue through the sale of these products to manufacturing and processing sectors.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
The company operates in the specialty chemicals industry, producing and selling chemical products for industrial applications, primarily generating revenue through the sale of these products to manufacturing and processing sectors.
The company's capital structure is highly leveraged, with a debt-to-equity ratio of 11.28, indicating a significant reliance on debt financing. Liquidity is constrained, as evidenced by a current ratio of 0.53, and the company reported negative operating and free cash flows of -69.45 million and -54.70 million CNY, respectively, in the latest period. This suggests the company is currently unable to generate sufficient cash to meet short-term obligations without external financing.
Profitability is severely underperforming relative to industry norms, with a return on equity of -1.11 and a return on assets of -0.07, both of which are negative and well below the typical thresholds for a specialty chemicals firm. The company reported a net loss of 58.65 million CNY, and operating income was also negative at -65.55 million CNY, indicating a failure to cover operating costs.
Geographic and segment exposure is not explicitly detailed in the available data, but the company's revenue is likely concentrated in domestic markets given the CNY-based financials and the absence of international revenue breakdowns. This lack of diversification could increase vulnerability to regional economic or regulatory shifts.
The company's growth trajectory is currently negative, with a net loss and declining cash flows. No specific revenue growth or decline percentages are provided, but the negative operating and free cash flows suggest a contraction in business activity or a deterioration in pricing and cost control. The company's capital expenditures were -18.81 million CNY, indicating a reduction in investment in long-term assets.
Risk factors include a high debt load and negative liquidity, with total liabilities exceeding total assets by 47.2 million CNY. The risk assessment flags a negative net cash position after subtracting total debt, which increases the company's exposure to liquidity risk and potential insolvency. Dilution risk is currently low, as there is no indication of share issuance or dilution in the latest financials.
Recent events or filings are not explicitly detailed in the available data, but the company's financial performance suggests a period of operational and financial stress. The negative net income and operating cash flow indicate a need for strategic or operational adjustments to restore profitability and liquidity.
- The company is highly leveraged, with a debt-to-equity ratio of 11.28, indicating a significant reliance on debt financing.
- Profitability is severely underperforming, with a return on equity of -1.11 and a return on assets of -0.07.
- Liquidity is constrained, with a current ratio of 0.53 and negative operating and free cash flows.
- The company is currently reporting a net loss and is unable to cover operating costs.
- There is no indication of international revenue diversification, suggesting a concentration risk in domestic markets.
- Dilution risk is currently low, but the company's financial position may require external financing in the near term.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- 300169.SZ Market data — financials · 2026-05-26